Skip to content

TMS Modulation of Insula-related Brain Networks.02

TMS Modulation of Insula-related Brain Networks.02

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02919423
Acronym
TMSINS02
Enrollment
36
Registered
2016-09-29
Start date
2016-12-31
Completion date
2018-01-25
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Brief summary

The purpose of this study is to investigate the modulatory effects of repetitive transcranial magnetic stimulation (rTMS) on functional connectivity with the insula. Functional connectivity (FC) measures the interaction between brain regions, and recent neuroimaging studies have used FC to investigate how addiction affects FC among pertinent brain regions. rTMS, which can excite cortical neurons, has shown promise as a method to manipulate brain connectivity and could be used therapeutically to treat addiction. However, investigators first need more information on brain FC and how it relates to behavior, in order to guide rTMS target selection.

Interventions

DEVICEtranscranial magnetic stimulation

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* generally healthy * between the ages of 18-55 * right-handed

Exclusion criteria

* significant health problems (e.g., current and uncontrolled liver, lung, or heart problems) or presence of medical illness likely to alter brain morphology (including history of seizure, history of epilepsy in self or first degree relatives, stroke, brain surgery, head injury, and known structural brain lesion) * current diagnosis of Axis I psychiatric disorders (e.g., depression, anxiety disorder, schizophrenia) * meet DSM-5 criteria for current substance use disorder other than nicotine * use of psychoactive medications that would result in a positive urine drug screen * Current use of medications known to lower the seizure threshold * positive breath alcohol concentration * presence of conditions that would make MRI unsafe (e.g., metal implants, pacemakers) * among women, a positive urine pregnancy test * vision that cannot be corrected to 20/40

Design outcomes

Primary

MeasureTime frameDescription
Change in Functional Connectivity Strength Measured With Functional Magnetic Resonance Imagingbaseline and 1 weekDifference in functional connectivity from the TMS target site to the right insula. The primary dependent variable was the resting-state functional connectivity strength between the TMS target site and the right insula.

Countries

United States

Participant flow

Pre-assignment details

5 subjects were consented but did not meet eligibility criteria and were not randomized to a condition.

Participants by arm

ArmCount
10 Hz TMS
This group received 10 Hz TMS
6
1 Hz TMS
This group received 1 Hz TMS
25
Total31

Baseline characteristics

Characteristic10 Hz TMS1 Hz TMSTotal
Age, Continuous27 years
STANDARD_DEVIATION 7
31 years
STANDARD_DEVIATION 12
30 years
STANDARD_DEVIATION 11
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Black or African American
0 Participants7 Participants7 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants14 Participants19 Participants
Region of Enrollment
United States
6 Participants25 Participants31 Participants
Sex: Female, Male
Female
3 Participants18 Participants21 Participants
Sex: Female, Male
Male
3 Participants7 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 25
other
Total, other adverse events
0 / 60 / 25
serious
Total, serious adverse events
0 / 60 / 25

Outcome results

Primary

Change in Functional Connectivity Strength Measured With Functional Magnetic Resonance Imaging

Difference in functional connectivity from the TMS target site to the right insula. The primary dependent variable was the resting-state functional connectivity strength between the TMS target site and the right insula.

Time frame: baseline and 1 week

ArmMeasureValue (NUMBER)
10 Hz TMSChange in Functional Connectivity Strength Measured With Functional Magnetic Resonance Imaging.25 correlation coefficient
1 Hz TMSChange in Functional Connectivity Strength Measured With Functional Magnetic Resonance Imaging.13 correlation coefficient

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026